Developmental trajectories of cocaine-and-other-drug-exposed and non-cocaine-exposed children

Journal of Developmental and Behavioral Pediatrics

Volumn 24, Issue 5, 2003, Pages 323-335

  Mayes, Linda C ^a   Cicchetti, Domenic ^a   Acharyya, Suddhasatta ^b   Zhang, Heping ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bayley Scales of Infant Development II; Growth curve analysis; Prenatal cocaine exposure

Indexed keywords

ALCOHOL; COCAINE;

AGE; AMBULATORY CARE; CHILD DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; GROWTH CURVE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENTAL DEVELOPMENT; MENTAL PERFORMANCE; MOTOR DEVELOPMENT; MOTOR PERFORMANCE; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; REVIEW; TIME; TOBACCO;

CHILD; CHILD DEVELOPMENT; COCAINE; FEMALE; HUMANS; INFANT; MENTAL PROCESSES; MOTOR SKILLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 0242363227     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004703-200310000-00003     Document Type: Review

References (67)

1. Azuma SD, Chasnoff IJ. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics. 1993;92:396-402.
2. Hurt H, Brodsky NL, Betancourt L, Braitman LE, et al. Cocaine-exposed children: follow-up through 30 months. J Dev Behav Pediatr. 1995;16:29-35.
3. Griffith DR, Azuma SD, Chasnoff U. Three-year outcome of children exposed prenatally to drugs. J Am Acad Child Adolesc Psychiatry. 1994;33:20-27.
4. Nulman I, Rovet J, Altmann D, Bradley C, Einarson T, Koren G. Neurodevelopment of adopted children exposed in utero to cocaine (see comments). Can Med Assoc J. 1994;151:1591-1597.
5. Mayes LC, Bornstein MH. Developmental dilemmas for cocaine-abusing parents and their children. In: Lewis M, Bendersky M, eds. Mothers, Babies, and Cocaine: The Role of Toxins in Development. Hillsdale, NJ: Lawrence Erlbaum Associates; 1995;251-272.
6. Graham K, Feigenbaum A, Pastuszak A, Nulman I, Weksberg R, Einarson T, Goldberg S, Ashby S, Koren G. Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada. Clin Invest Med. 1992;15:384-394.
7. Chasnoff IJ, Griffith DR, Freier C, Murray J. Cocaine/polydrug use in pregnancy: two-year follow-up (see comments). Pediatrics. 1992; 89:284-289.
8. Bayley N. The Bayley Scales of Infant Development. New York, NY: The Psychological Corporation; 1993.
9. Mayes LC, Bornstein MH, Chawarska K, Granger RH. Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics. 1995;95:539-545.
10. Arendt R, Angelopoulos J, Salvator A, Singer L. Motor development of cocaine-exposed children at age two years. Pediatrics. 1999; 103:86-92.
11. Arendt R, Singer L, Angelopoulos J, Bass-Busidiecker O, Mascia J. Sensorimotor development in cocaine-exposed infants. Infant Behav Dev. 1998;21:627-640.
12. Richardson G, Day M, McGauhey P. The impact of prenatal marijuana and cocaine use on the infant and child. Clin Obstet Gynecol. 1993;36:302-318.
13. Hurt H, Malmud E, Betancourt L, Braitman LE, Brodsky NL, Giannetta J. Children with in utero cocaine exposure do not differ from control subjects on intelligence testing. Arch Pediatr Adolesc Med. 1997;151:1237-1241.
14. Richardson G, Conroy M, Day N. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol. 1996;18:627-634.
15. Phelps L, Cottone JW. Long-term developmental outcome of prenatal cocaine exposure. J Psychoeducat Assess. 1999;17:343-353.
16. Alessandri SM, Bendersky M, Lewis, M. Cognitive functioning in 8- to 18-month old drug-exposed infants. Dev Psychol. 1998;34:565-573.
17. Richardson G. Prenatal cocaine exposure: a longitudinal study of development. Ann N Y Acad Sci. 1998;846:144-152.
18. Koren G, Nulman I, Rovet J, Greenbaum R, Loebstein M, Einarson T. Long-term neurodevelopmental risks in children exposed in utero to cocaine. The Toronto Adoption Study. Ann N Y Acad Sci. 1998;846:306-313.
19. Barron S, Irvine J. Effects of neonatal cocaine exposure on two measures of balance and coordination. Neurotoxicol Teratol. 1994; 16:89-94.
20. Bendersky M, Lewis, M. Prenatal cocaine exposure and impulse control at two years. Ann N Y Acad Sci. 1998;846:365-367.
21. Griffith DR, Azuma SD, Chasnoff IJ. Three-year outcome of children exposed prenatally to drugs. Special Section: Cocaine Babies. J Am Acad Child Adolesc Psychiatry. 1994;33:20-27.
22. Jacobson SW, Jacobson JL, Sokol RJ, Martier SS, Chiodo LM. New evidence for neurobehavioral effects of in utero cocaine exposure. J Pediatr. 1996;129:581-590.
23. Alessandri S, Sullivan M, Imaizumi S, Lewis M. Learning and emotional responsivity in cocaine-exposed infants. Dev Psychol. 1993;29:989-997.
24. Struthers JM, Hansen, RL. Visual recognition memory in drug-exposed infants. J Dev Behav Pediatr. 1992;13:108-111.
25. Hansen RL, Struthers JM, Gospe SM Jr. Visual evoked potentials and visual processing in stimulant drug-exposed infants. Dev Med Child Neurol. 1993;35:798-805.
26. Mayes LC, Grillon C, Granger R, Schottenfeld R. Regulation of arousal and attention in preschool children exposed to cocaine prenatally. Ann N Y Acad Sci. 1998;846:126-143.
27. Metosky P, Vondra J. Prenatal drug exposure and play and coping in toddlers: a comparative study. Infant Behav Dev. 1995;18:15-25.
28. Mayes LC, Fahy T. Prenatal drug exposure and cognitive development. In: Sternberg RJ, Grigorenko EL, eds. Environmental Effects on Cognitive Abilities. Mahwah, NJ: Lawrence Erlbaum Associates; 2001;189-220.
29. Singer L, Arendt R, Minnes S, Farkas K, Salvator A. Neurobehavioral outcomes of cocaine-exposed infants. Neurotoxicol Teratol. 2000;22:653-666.
30. Olsen GD. Potential mechanisms of cocaine-induced developmental neurotoxicity. Neurotoxicology. 1995;16:159-167.
31. Mayes LC. Neurobiology of prenatal cocaine exposure effect on developing monoamine systems. Special Issue: Prenatal Drug Exposure and Child Outcome. Infant Ment Health J. 1994;15:121-133.
32. Mayes LC. Developing brain and in-utero cocaine exposure: effects on neural ontogeny. Dev Psychopathol. 1999;11:685-714.
33. Fantel A, Barber C, Mackler B. Ischemia/reperfusion: a new hypothesis for the developmental toxicity of cocaine. Teratology. 1992;46:285-292.
34. Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant (see comments). Pediatrics. 1989;84:205-210.
35. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111: 571-578.
36. Woods JR Jr, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257:957-961.
37. Poklis A. Evaluation of TDx cocaine metabolite assay. J Anal Toxicol. 1987;11:228-230.
38. Walters R. An abused drug assay system. Am Clin Prod Rev. 1987; March.
39. Armbruster D, Schwarzhoff R, Hubster E, Liserio M. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening. Clin Chem. 1993;39:2137-2146.
40. Simpson D, Jarvie DR, Heyworth R. An evaluation of six methods for the detection of drugs of abuse in urine. Ann Clin Biochem. 1989;26:172-181.
41. Sedman AJ, Molitoris BA, Nakata LM, Gal J. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system. Am J Nephrol. 1986;6:132-134.
42. Littman D, Parmelee A. Medical correlates of infant development. Pediatrics. 1978;77:209-211.
43. Abidin R. The Parenting Stress Index. 3rd ed. (Manual). Odessa, Florida: Psychological Assessment Resources; 1995.
44. Leach C. Introduction to Statistics: A Nonparametric Approach for the Social Sciences. New York, NY: Wiley; 1979.
45. Jonckheere AR. A test of significance for the relation between m rankings and k ranked categories. Br J Stat Psychol. 1954;7:93-100.
46. Yates F. Contingency tables involving small numbers and the 2 test. J Royal Stat Soc. 1934;1(suppl):217-235.
47. Laird N, Ware J. Random-effects models for longitudinal data. Biometrics. 1982;38:939-974.
48. Ellis JE, Byrd LD, Sexson WR, Patterson-Barnett CA. In utero exposure to cocaine: a review. South Med J. 1993;86:725-731.
49. Koren G, Graham K. Cocaine in pregnancy: analysis of fetal risk. Vet Hum Toxicol. 1992;34:263-264.
50. Delaney-Black V, Covington C, Templin T, Kershaw T, Nordstrom-Klee B, Ager J, Clark N, Surendran A, Martier S, Sokol R. Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J Commun Disord. 2000;33:463-481.
51. Mayes LC, Feldman R, Granger RH, Haynes OM, Bornstein MH, Schottenfeld R. The effects of polydrug use with and without cocaine on mother-infant interaction at 3 and 6 months. Infant Behav Dev. 1997;20:489-502.
52. Beckwith L, Howard J, Espinosa M, Tyler R. Psychopathology, mother-child interaction, and infant development: substance-abusing mothers and their offspring. Dev Psychopathol. 1999;11:715-725.
53. Burns K, Chethik L, Burns WJ, Clark R. Dyadic disturbances in cocaine-abusing mothers and their infants. J Clin Psychol. 1991; 47:316-319.
54. Fitzgerald E, Kaltenbach K, Finnegan L. Patterns of interactions among drug dependent women and their infants. Pediatr Res. 1990;25:10A.
55. Lustbader AS, Mayes LC, McGee BA, Jatlow P, Roberts WL. Incidence of passive exposure to crack/cocaine and clinical findings in infants seen in an outpatient service. Pediatrics. 1998;102:1.
56. Kharasch SJ, Glotzer D, Vinci K, Weitzman M, Sargent J. Unsuspected cocaine exposure in young children. Am J Dis Child. 1991;145:204-206.
57. Gidding SS, Schydlower M. Active and passive tobacco exposure: a serious pediatric health problem. Pediatrics. 1994;94:750-751.
58. Hayden JW. Passive inhalation of marijuana smoke: a critical review. J Subst Abuse. 1991;3:85-90.
59. Ollo C, Lindquist T, Alim TN, Deutsch SI. Predicting premorbid functioning in crack-cocaine abusers. Drug Alcohol Depend. 1995; 40:173-175.
60. Bornstein MH, Hahn C-S, Suwalsky JTD, Haynes OM. Socioeconomic status, parenting, and child development: the Hollingshead Four-Factor Index of Social Status and the Socioeconomic Index of Occupations. In: Bornstein MH, Bradley RH, eds. Socioeconomic Status, Parenting, and Child Development. Mahwah, NJ: Lawrence Erlbaum Associates; 2003;29-82.
61. Streissguth A, Barr H, Sampson P, Parrish-Johnson J, Kirchner G, Martin D. Attention, distraction, and reaction time at age 7 years and prenatal alcohol exposure. Neurobehav Toxicol Teratol. 1986;8:717-725.
62. Streissguth A, Barr H, Sandman B, Kirchner B, Darby B. Intrauterine alcohol and nicotine exposure: attention and reaction time in 4-year-old children. Dev Psychol. 1984;20:533-541.
63. Jacobson SW, Fein GG, Jacobson JL, Schwartz PM, Dowler JK. Neonatal correlates of prenatal exposure to smoking, caffeine, and alcohol. Infant Behav Dev. 1984;7:253-265.
64. Gusella JL, Fried P. Effects of maternal social drinking and smoking on offspring at 13 months. Neurobehav Toxicol Teratol. 1984;6:13-17.
65. Richardson GA, Ryan C, Wllford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002;24:311-320.
66. Kaplan-Estrin M, Jacobson SW, Jacobson JL. Neurobehavioral effects of prenatal alcohol exposure at 26 months. Neurotoxicol Teratol. 1999;21:503-511.
67. Olds D. Tobacco exposure and impaired development: a review of the evidence. Ment Retard Dev Disabil Res Rev. 1997;3:257-269.